| Literature DB >> 28348736 |
Mia Kolmos1, Rikke Steen Krawcyk2, Christina Kruuse1.
Abstract
OBJECTIVES: Exercise improves endothelial dysfunction, the key manifestation of cardiovascular and cerebrovascular disease, and is recommended in both cardiovascular and cerebrovascular rehabilitation. Disagreement remains, however, on the role of intensity of exercise. The purpose of this review was to gather current knowledge on the effects of high-intensity training versus moderate-intensity continuous exercise on endothelial function in cardiovascular and cerebrovascular patients.Entities:
Keywords: Vascular endothelium; aerobic exercise; endothelial function; flow-mediated dilatation; high-intensity exercise; high-intensity training; interval training
Year: 2016 PMID: 28348736 PMCID: PMC5354182 DOI: 10.1177/2050312116682253
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Figure 1.The general effects of exercise. The effect of exercise targets various organ systems thus improving cardiovascular, endothelial, cerebral and metabolic function, all parameters important to improve rehabilitation and reduce stroke risk. The figure depicts the various physiological systems affected. Increased flow in the vessels induced by exercise activates endothelial mechanoreceptors initiating synthesis of nitric oxide (NO) through activation of endothelial nitric oxide synthase (eNOS). Nitric oxide release is involved in both processes of vasodilation and inflammation. Dysfunction of the endothelium increases risk of platelet aggregation and leukocyte infiltration through adhesion molecules. Furthermore, exercise improving muscle and cardiac function improves the metabolism of glucose and cholesterol.
Illustration is created with inspiration from Schmidt et al.[2]
PubMed search strategy.
| Patients | Intervention | Comparison | Outcome |
|---|---|---|---|
| “High-intensity training” | Endothelium, Vascular [Mesh] | ||
| “High intensity training” | “Endothelium, Vascular” | ||
| “Interval training” | “endothelial function” | ||
| “Interval exercise training” | |||
| “High intensity exercise” | |||
| “High intensity aerobic interval training” | |||
| “Aerobic exercise” |
Overview of participants and exercise interventions.
| Reference | Design | Blinded | Participants number and diagnosis | Exercise intervention | ||
|---|---|---|---|---|---|---|
| Mode: HIT, MICE, control | Protocol | Duration (weeks) | ||||
| Yamamoto et al.[ | Non-randomized trial | No | 10 healthy participants | HIT | • A single bout of HIT | 0 |
| Wisløff et al.[ | RCT | Yes | 27 participants with post-infarction HF | MICE, HIT, control | • 3 MICE/HIT sessions per week either or control | 12 |
| Rognmo et al.[ | Non-randomized trial | No | 10 athletes | HIT | • A single bout of HIT session | 0 |
| Rakobowchuk et al.[ | RCT | No | 20 healthy untrained participants | HIT, MICE | • HIT session 3 times per week or MICE 5 times per week | 6 |
| Munk et al.[ | RCT | Yes | 40 participants after PCI—implantation of bare metal stent or drug eluting stent. | HIT, control | • 3 HIT sessions per week or control | 24 |
| Hermann et al.[ | RCT | Yes | 27 long-term heart transplant recipients | HIT, control | • 3 HIT sessions per week or control | 8 |
| Moholdt et al.[ | RCT | Yes | 107 CAD patients | HIT, MICE | • 2 weekly exercise sessions | 12 |
| Currie et al.[ | Within-subject repeated-measures design | No | 10 CAD patients | HIT, MICE | • 2 exercise sessions separated by an average of 11 days. Order of condition was randomized. | 0 |
| Rakobowchuk et al.[ | Controlled study | No | 20 healthy participants | HIT | • | 6 |
| Morikawa et al.[ | Non-randomized study | No | 26 patients with rest or effort angina | HIT | • 3 successive days of exercise | 0 |
| Guiraud et al.[ | Within-subject repeated-measures design | No | 19 CAD patients | HIT, MICE | • 2 exercise sessions separated by 14 days | 0 |
| Isaksen et al.[ | Non-randomized study | Yes | 38 patients with ICD | HIT, control | • 3 sessions per week | 12 |
| Angadi et al.[ | RCT | Yes | 19 HFpEF patients. | HIT, MICE | • 3 sessions per week of either HIT or MICE | 4 |
| Wahl et al.[ | Within-subject repeated-measures design | No | 12 triathletes/cyclists | HIT, MICE | • One session of 3 different protocols with 1 week between | 0 |
| Conraads et al.[ | RCT | Yes | 200 CAD participants. | HIT, MICE | • 3 sessions per week of either HIT or MICE | 12 |
| Dall et al.[ | RCT | Yes | 16 heart transplant recipients | HIT, MICE | • 3 sessions per week of either HIT or MICE | 12 |
| Van Craenenbroeck et al.[ | RCT | Yes | 200 CAD participants. | HIT, MICE | • | 12 |
HIT: high-intensity training; MICE: moderate-intensity continuous exercise; HF: heart failure; HR: heart rate; CAD: coronary artery disease; RCT: randomized controlled trial; ICD: implantable cardioverter defibrillator; VO2max: maximum capacity for aerobic work; HFpEF: heart failure with preserved ejection fraction; PPO: peak power output; PCI: percutaneous coronary intervention.
Overview of results.
| Reference | Outcome | Conclusions | |
|---|---|---|---|
| Yamamoto et al.[ | • No significant difference in serum NOx products pre- or post-exercise | N.S. | ⇓HIT |
| Wisløff et al.[ | • | <0.05 | HIT > MICE > controls |
| Rognmo et al.[ | • | <0.02 | ⇓HIT |
| Rakobowchuk et al.[ | • | <0.05 | HIT = MICE |
| Munk et al.[ | • | 0.01 | HIT > controls |
| Hermann et al.[ | • | 0.024 | HIT > controls |
| Moholdt et al.[ | • | N.S. | HIT = MICE |
| Currie et al.[ | • | <0.05 | HIT = MICE |
| Rakobowchuk et al.[ | • | 0.33 | ⇓HIT |
| Morikawa et al.[ | • | <0.001 | ⇑HIT |
| Guiraud et al.[ | • | N.S. | ⇓HIT, MICE |
| Isaksen et al.[ | • | 0.019 | HIT > controls |
| Angadi et al.[ | • | N.S. | ⇓HIT, MICE |
| Wahl et al.[ | • | <0.004 and <0.006 | HIT = MICE |
| Conraads et al.[ | • | <0.001 | HIT = MICE |
| Dall et al.[ | • | N.S. | ⇓HIT, MICE |
| Van Craenenbroeck et al.[ | • | ⇓HIT, MICE |
HIT: high-intensity training; MICE: moderate-intensity continuous exercise; FMD: flow-mediated dilatation; N.S.: not significant; <: better than; ⇑/⇓: positive effect/no change; [EMP]: concentration of EMP; EMP: endothelial microparticle; EPC: endothelial progenitor cells; VEGF: vascular endothelial growth factor; HVT: high-volume training; RHI: reactive hyperemia index.
Except in two participants.
Figure 2.Flow diagram of selection process.